Kuzu, O. F., Bolek, H., Camoz, E. S., Karakas, H., Sekmek, S., Sim, S., . . . Ürün, Y. Impact of first-line tyrosine kinase inhibitor selection on survival outcomes with second-line nivolumab in metastatic renal cell carcinoma. BMC.
Chicago Style (17th ed.) CitationKuzu, Omer Faruk, et al. Impact of First-line Tyrosine Kinase Inhibitor Selection on Survival Outcomes with Second-line Nivolumab in Metastatic Renal Cell Carcinoma. BMC.
MLA (9th ed.) CitationKuzu, Omer Faruk, et al. Impact of First-line Tyrosine Kinase Inhibitor Selection on Survival Outcomes with Second-line Nivolumab in Metastatic Renal Cell Carcinoma. BMC.
Warning: These citations may not always be 100% accurate.